Long‑term outcomes after revascularization and medical therapy in premature coronary artery disease for cost‑effectiveness study: A systematic review protocol
نویسندگان
1 Department of Health Economics, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran
2 Department of Health Economics, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran
3 Cardiovascular Department, Rasoul Akram General Hospital, Iran University of Medical Sciences, Tehran, Iran
4 Department of Industrial Engineering, Islamic Azad University West Tehran Branch, Tehran, Iran
5
doi
چکیده
BACKGROUND: The long‑term outcomes are important concepts for cost‑effectiveness analysisin patients with premature coronary artery disease after revascularization (coronary artery bypassgrafting [CABG] and percutaneous coronary intervention [PCI]) and medical therapy (MT). Thefinding of this study will be used to calculate the events probabilities for cost‑effectiveness study.METHODS AND ANALYSIS: This systematic review will use studies in which patients age must be18–60 years in eligible studies that obtained from PubMed, Web of Science, Scopus, and Embase.We will assess the long‑term outcomes after CABG, PCI, and MT by random‑effects meta‑analysisand effects will be shown by risk ratio. We will ascertain the probabilities of adverse events duringcertain periods and then outcomes will compare separately based on specific characteristics.CONCLUSION: This study will provide information related to outcomes of CABG, PCI, and MTin patients with premature coronary artery disease. Doing this systematic review is valuable fromclinically and economically aspects such as cost‑effectiveness and cost‑utility analysis.
